Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Céline Montavon, Irene Hoesli, Wolfgang Holzgreve & Dimitrios A. Tsakiris. (2008) Thrombophilia and anticoagulation in pregnancy: indications, risks and management. The Journal of Maternal-Fetal & Neonatal Medicine 21:10, pages 685-696.
Read now
Read now
William E Wade & William J Spruill. (2007) Fondaparinux sodium in the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism. Expert Review of Pharmacoeconomics & Outcomes Research 7:3, pages 227-237.
Read now
Read now
Articles from other publishers (16)
Jingdong Rao, Xiaohui Mou, Yongyi Mo, Ho-Pan Bei, Li Wang, Chuyang Y. Tang, Kai-Hang Yiu, Zhilu Yang & Xin Zhao. (2023) Gas station in blood vessels: An endothelium mimicking, self-sustainable nitric oxide fueling stent coating for prevention of thrombosis and restenosis. Biomaterials 302, pages 122311.
Crossref
Crossref
Connor Watson, Hicham Saaid, Vijay Vedula, Jessica C. Cardenas, Peter K. Henke, Franck Nicoud, Xiao Yun Xu, Beverley J. Hunt & Keefe B. Manning. (2023) Venous Thromboembolism: Review of Clinical Challenges, Biology, Assessment, Treatment, and Modeling. Annals of Biomedical Engineering.
Crossref
Crossref
S. Patterson, M. de Kort, N. Irwin, R. C. Moffett, W. H. A. Dokter, E. S. Bos, A. M. M. Miltenburg & P. R. Flatt. (2015) Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide. Diabetes, Obesity and Metabolism 17:8, pages 760-770.
Crossref
Crossref
Nigel Irwin, Steven Patterson, Martin de?Kort, R. Charlotte Moffett, Jeffry A. J. Wisse, Wim H. A. Dokter, Ebo S. Bos, Andr? M. M. Miltenburg & Peter R. Flatt. (2015) Synthesis and Evaluation of a Series of Long-Acting Glucagon-Like Peptide-1 (GLP-1) Pentasaccharide Conjugates for the Treatment of Type?2 Diabetes. ChemMedChem 10:8, pages 1424-1434.
Crossref
Crossref
Kamil Kamiński, Monika Płonka, Justyna Ciejka, Krzysztof Szczubiałka, Maria Nowakowska, Barbara Lorkowska, Ryszard Korbut & Radosław Lach. (2011) Cationic Derivatives of Dextran and Hydroxypropylcellulose as Novel Potential Heparin Antagonists. Journal of Medicinal Chemistry 54:19, pages 6586-6596.
Crossref
Crossref
Yu‐Kai Lee & Mark R. Player. (2011) Developments in factor Xa inhibitors for the treatment of thromboembolic disorders. Medicinal Research Reviews 31:2, pages 202-283.
Crossref
Crossref
Donald J. AbrahamBrian L. Henry & Umesh R. Desai. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
365
408
.
Lori-Ann Linkins & Jeffrey I. Weitz. (2010) New and Emerging Anticoagulant Therapies for Venous Thromboembolism. Current Treatment Options in Cardiovascular Medicine 12:2, pages 142-155.
Crossref
Crossref
Thierry Huet, Olivier Kerbarh, Dominique Schols, Pascal Clayette, Cécile Gauchet, Guy Dubreucq, Loïc Vincent, Heidi Bompais, Romain Mazinghien, Olivier Querolle, Arnaud Salvador, Jérôme Lemoine, Bruno Lucidi, Jan Balzarini & Maurice Petitou. (2010) Long-Lasting Enfuvirtide Carrier Pentasaccharide Conjugates with Potent Anti-Human Immunodeficiency Virus Type 1 Activity. Antimicrobial Agents and Chemotherapy 54:1, pages 134-142.
Crossref
Crossref
Takuya Fujimoto, Mamoru Tobisu, Noriko Konishi, Masaki Kawamura, Norio Tada, Terufumi Takagi & Keiji Kubo. (2009) Synthesis and biological evaluation of the metabolites of 2-(1-{3-[(6-chloronaphthalen-2-yl)sulfonyl]propanoyl}piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one. Bioorganic & Medicinal Chemistry 17:23, pages 7993-8002.
Crossref
Crossref
Pieter W. Kamphuisen & Harry R. Büller. 2009. New Therapeutic Agents in Thrombosis and Thrombolysis. New Therapeutic Agents in Thrombosis and Thrombolysis
253
268
.
P. SAVI, J.P. HERAULT, P. DUCHAUSSOY, L. MILLET, P. SCHAEFFER, M. PETITOU, F. BONO & J.M. HERBERT. (2008) Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy. Journal of Thrombosis and Haemostasis 6:10, pages 1697-1706.
Crossref
Crossref
Martin de Kort, Bas Gianotten, Jeffry A. J. Wisse, Ebo S. Bos, Michel H. M. Eppink, Ellen Mattaar, Gerard M. T. Vogel, Wim H. A. Dokter, Maarten Honing, Stanislava Vonsovic, Martin-Jan Smit, Jac C. H. M. Wijkmans & Constant A. A. van Boeckel. (2008) Conjugation of ATIII-Binding Pentasaccharides to Extend the Half-Life of Proteins: Long-Acting Insulin. ChemMedChem 3:8, pages 1189-1193.
Crossref
Crossref
Peter L. GrossJeffrey I. Weitz. (2008) New Anticoagulants for Treatment of Venous Thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology 28:3, pages 380-386.
Crossref
Crossref
Rémi Varin, Shahsultan Mirshahi, Pezhman Mirshahi, Gerald Kierzek, David Sebaoun, Zohar Mishal, Jean-Pierre Vannier, Jeanne Yvonne Borg, Guy Simoneau, Claudine Soria & Jeannette Soria. (2017) Clot structure modification by fondaparinux and consequence on fibrinolysis: A new mechanism of antithrombotic activity. Thrombosis and Haemostasis 97:01, pages 27-31.
Crossref
Crossref
Agnes YY Lee. (2006) Dalteparin sodium in the management of thromboembolic disorders. Therapy 3:4, pages 461-473.
Crossref
Crossref